CRISPR Therapeutics AG (CRSP): New Bullish Coverage

CRSP – JMP Securities initiates as a market outperform, $69PT. This price target represents a 34.01% upside over the stock’s previous closing price of $51.49.

Update: As of Mar. 22, 2018, this bullish analyst call has returned -0.66%.

Key Facts Surrounding This News Item

  • CRSP had a POWR Rating of A (Strong Buy) coming into today.
  • CRSP was 8.53% above its 10-Day Moving Average coming into today.
  • CRSP was 18.27% above its 20-Day Moving Average coming into today.
  • CRSP was 43.76% above its 50-Day Moving Average coming into today.
  • CRSP was 88.84% above its 100-Day Moving Average coming into today.
  • CRSP was 130.79% above its 200-Day Moving Average coming into today.
  • CRSP had returned +119.29% year-to-date leading up to today’s news, versus a +2.22% return from the benchmark S&P 500 during the same period.

More Info About CRISPR Therapeutics AG (CRSP)

CRISPR Therapeutics AG focuses on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The company is based in Basel, Switzerland. View our full CRSP ticker page with ratings, news, and more.

Try Premium Today!

Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

CRSP at a Glance

CRSP Current POWR Rating™
Overall POWR Rating™
CRSP Current Price $51.15 1.94%
More CRSP Ratings, Data, and News

CRSP Price Reaction

The day of this event (Mar. 8, 2018)
CRSP Closing Price$53.70 4.29%
CRSP Volume1,059,300
219.92% from avg
Leading up to this event
CRSP 1-mo return33.26%
After this event
CRSP 1-day return9.22%
CRSP 3-day return8.88%
CRSP 5-day return2.11%

CRSP Price Chart

More CRISPR Therapeutics AG (CRSP) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CRSP News
Page generated in 1.1116 seconds.